United States · Series B startup

Who invested in Groove Biopharma

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$9.9Mraised across 2 rounds since 2010, from 2 sources

$3.9MSeries A$6.0MSeries B
Latest round
Series B, $6.0MDec 2011
Step-upi
1.5×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011
$3.9MSeries A$6.0MSeries B
First round
Series A, $3.9M
Apr 2010
Biggest round
$6.0M
Series B · Dec 2011
Between rounds
20 months
from the last two

The rounds

  1. Dec 2011
    Series B$6.0M4 returning

    Reported by finsmes.comSEC filing: $4.5M sold, first sale Dec 2011

  2. Apr 2010

Founders and team

From the SEC filings it signed: 3 on the team.

  • Carl WeissmanExecutive Officer, Directori
  • David SchubertExecutive Officeri
  • Lindsay RayleExecutive Officeri

On the board, as filediBrian AtwoodChad WaiteMerl F. HoekstraSteven GillisThong Le

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Groove Biopharma

Who invested in Groove Biopharma?

Groove Biopharma's investors include ARCH Venture Partners, Versant Ventures, OVP Venture Partners, Washington Research Foundation and Alexandria Real Estate Equities.

How much has Groove Biopharma raised?

Groove Biopharma has raised $9.9M across 2 rounds since 2010.

When did Groove Biopharma last raise?

Groove Biopharma's most recent round was a Series B of $6.0M in Dec 2011.

What was Groove Biopharma's biggest round?

Its most recent round, $6.0M in Dec 2011, is also its largest on record.

Who backed Groove Biopharma first?

Groove Biopharma's first round on record, in Apr 2010, was backed by ARCH Venture Partners, Versant Ventures and Alexandria Real Estate Equities and 2 others.

What stage is Groove Biopharma at?

Groove Biopharma's latest named round is a Series B, in Dec 2011.

Where is Groove Biopharma based?

Groove Biopharma is based in the United States.

Companies like Groove Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.